| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |